Literature DB >> 25063190

The Patient Education Program for Huntington's Disease (PEP-HD).

Laura E I A'Campo1, Noëlle G A Spliethoff-Kamminga2, Raymund A C Roos2.   

Abstract

The goal of the Patient Education Program for Huntington's disease is to improve quality of life for patients and caregivers, to educate and train them in order to develop coping strategies to deal with psychosocial stressors. The program was derived from a standardized evidence-based program for Parkinson's disease. This pilot study assessed the feasibility of the program in Huntington's disease. Forty manifest patients with 28 caregivers and 19 premanifest carriers with 14 partners participated. Assessments for depression and anxiety, psychosocial burden, need for help, quality of life, coping, behavioral, motor and cognitive status were performed. After program completion, significant improvement of behavioral symptoms and anxiety was found for manifest HD patients, and they used a less passive coping style and more social support. Their caregivers reported less psychosocial burden. Premanifest carriers and their partners improved their coping by seeking social support more often. This pilot study demonstrated the feasibility of the program in Huntington's disease, especially in the manifest stage of the disease. Further research to assess the effectiveness of the program seems warranted.

Entities:  

Keywords:  Huntington's disease; caregivers; psychosocial aspects; training support

Mesh:

Year:  2012        PMID: 25063190     DOI: 10.3233/JHD-2012-120002

Source DB:  PubMed          Journal:  J Huntingtons Dis        ISSN: 1879-6397


  1 in total

Review 1.  Perceived Benefits and Facilitators and Barriers to Providing Psychosocial Interventions for Informal Caregivers of People with Rare Diseases: A Scoping Review.

Authors:  Danielle B Rice; Andrea Carboni-Jiménez; Mara Cañedo-Ayala; Kimberly A Turner; Matthew Chiovitti; Alexander W Levis; Brett D Thombs
Journal:  Patient       Date:  2020-10       Impact factor: 3.883

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.